These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 31581907
1. Efficacy and safety of second-line treatment in Thai patients with primary warm-type autoimmune hemolytic anemia. Hantaweepant C, Pairattanakorn P, Karaketklang K, Owattanapanich W, Chinthammitr Y. Hematology; 2019 Dec; 24(1):720-726. PubMed ID: 31581907 [Abstract] [Full Text] [Related]
2. Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia. Rattarittamrong E, Eiamprapai P, Tantiworawit A, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Norasetthada L. Hematology; 2016 Jul; 21(6):368-74. PubMed ID: 27077773 [Abstract] [Full Text] [Related]
4. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies. Reynaud Q, Durieu I, Dutertre M, Ledochowski S, Durupt S, Michallet AS, Vital-Durand D, Lega JC. Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766 [Abstract] [Full Text] [Related]
5. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. D'Arena G, Califano C, Annunziata M, Tartarone A, Capalbo S, Villani O, Amendola G, Pietrantuono G, Ferrara F, Pinto A, Musto P, D'Arco AM, Cascavilla N. Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766 [Abstract] [Full Text] [Related]
7. [The clinical features of the autoimmune hemolytic anemia with both warm and cold autoantibodies]. Xing LM, Shao ZH, Liu H, Shi J, Bai J, Wang HQ, Tu MF, Sun J. Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):42-4. PubMed ID: 16732941 [Abstract] [Full Text] [Related]
8. Autoimmune Hemolytic Anemia in the Pediatric Age Group: The Egyptian Experience. Abdel-Salam A, Bassiouni ST, Goher AM, Shafie ES. Ann Hematol; 2023 Jul; 102(7):1687-1694. PubMed ID: 37093240 [Abstract] [Full Text] [Related]
9. [Progress in diagnosis and treatment of autoimmune hemolytic disorders]. Kamesaki T. Rinsho Ketsueki; 2017 Jul; 58(4):329-335. PubMed ID: 28484163 [Abstract] [Full Text] [Related]
10. Autoimmune hemolytic anemia in children. Naithani R, Agrawal N, Mahapatra M, Kumar R, Pati HP, Choudhry VP. Pediatr Hematol Oncol; 2007 Jun; 24(4):309-15. PubMed ID: 17613874 [Abstract] [Full Text] [Related]
13. Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA. Laribi K, Bolle D, Ghnaya H, Sandu A, Besançon A, Denizon N, Truong C, Pineau-Vincent F, de Materre AB. Ann Hematol; 2016 Apr; 95(5):765-9. PubMed ID: 26858026 [Abstract] [Full Text] [Related]
14. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study. Li H, Ji J, Du Y, Huang Y, Gu H, Chen M, Wu R, Han B. Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553 [Abstract] [Full Text] [Related]
16. Current treatment strategies in autoimmune hemolytic disorders. Barcellini W. Expert Rev Hematol; 2015 Oct; 8(5):681-91. PubMed ID: 26343892 [Abstract] [Full Text] [Related]
17. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A. J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092 [Abstract] [Full Text] [Related]
18. Danazol in autoimmune haemolytic anaemia. Pignon JM, Poirson E, Rochant H. Br J Haematol; 1993 Feb; 83(2):343-5. PubMed ID: 8457484 [Abstract] [Full Text] [Related]